The estimated Net Worth of Helen M Boudreau is at least $446 Tisíc dollars as of 15 May 2024. Ms. Boudreau owns over 6,629 units of Premier Inc stock worth over $314,753 and over the last 9 years she sold PINC stock worth over $131,586. In addition, she makes $0 as Independent Director at Premier Inc.
Helen has made over 1 trades of the Premier Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently she sold 6,629 units of PINC stock worth $131,586 on 15 May 2024.
The largest trade she's ever made was selling 6,629 units of Premier Inc stock on 15 May 2024 worth over $131,586. On average, Helen trades about 414 units every 0 days since 2016. As of 15 May 2024 she still owns at least 16,067 units of Premier Inc stock.
You can see the complete history of Ms. Boudreau stock trades at the bottom of the page.
Helen M. Boudreau has been appointed as Independent Director of the Company effective 6/1/2020. She served as the Chief Operating Officer of the Bill and Melinda Gates Medical Research Institute, a nonprofit medical research organization, from June 2018 to June 2019. Previously, she served as the Chief Financial Officer at each of Proteostasis Therapeutics, Inc., a NASDAQ-listed biopharmaceutical company, from July 2017 to June 2018, and FORMA Therapeutics, Inc., a privately-held biotechnology company, from October 2014 to June 2017. Her prior experience includes executive positions with Novartis Corporation and Pfizer, Inc. and leadership roles with Pepsico/Yum! Brands, Inc., McKinsey & Company, Inc. and Bank of America Corporation. Ms. Boudreau served on the Board of Directors and as Chair of the Audit Committee and member of the Compensation Committee for Proteostasis Therapeutics, Inc. from 2016 to 2017. She also provides services on the Boards of Directors of two private healthcare-related companies. She obtained a bachelor’s degree from the University of Maryland and a Master of Business Administration from the University of Virginia Darden Graduate School of Business.
Helen Boudreau is 54, she's been the Independent Director of Premier Inc since 2020. There are 19 older and 5 younger executives at Premier Inc. The oldest executive at Premier Inc is Marvin O'Quinn, 67, who is the Director.
Helen's mailing address filed with the SEC is C/O SHATTUCK LABS, INC., 500 W. 5TH STREET, SUITE 1200, AUSTIN, TX, 78701.
Over the last 11 years, insiders at Premier Inc have traded over $25,805,748 worth of Premier Inc stock and bought 58,600 units worth $1,642,100 . The most active insiders traders include Marc D Miller, Craig S. Mc Kasson a Michael J. Alkire. On average, Premier Inc executives and independent directors trade stock every 38 days with the average trade being worth of $320,590. The most recent stock trade was executed by Andy Brailo on 6 September 2024, trading 21,390 units of PINC stock currently worth $436,998.
as a leading national healthcare solutions organization, premier, inc. collaborates with healthcare organizations to improve supply chain management, decrease healthcare costs, integrate data and improve the health of communities. as an industry leader, premier has created one of the most comprehensive database of actionable data, best practices and cost reduction strategies. we enable our members to collaborate easily and efficiently improve their quality outcomes, while reducing costs. by engaging members and revealing new opportunities, we empower our alliance to improve performance like no one else in healthcare can.
Premier Inc executives and other stock owners filed with the SEC include: